Cargando…
Use of Antimony in the Treatment of Leishmaniasis: Current Status and Future Directions
In the recent past the standard treatment of kala-azar involved the use of pentavalent antimonials Sb(V). Because of progressive rise in treatment failure to Sb(V) was limited its use in the treatment program in the Indian subcontinent. Until now the mechanism of action of Sb(V) is not very clear. R...
Autores principales: | Haldar, Arun Kumar, Sen, Pradip, Roy, Syamal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE-Hindawi Access to Research
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196053/ https://www.ncbi.nlm.nih.gov/pubmed/22091408 http://dx.doi.org/10.4061/2011/571242 |
Ejemplares similares
-
Leishmania donovani Isolates with Antimony-Resistant but Not -Sensitive Phenotype Inhibit Sodium Antimony Gluconate-Induced Dendritic Cell Activation
por: Haldar, Arun Kumar, et al.
Publicado: (2010) -
Peptides to Tackle Leishmaniasis: Current Status and Future Directions
por: Robles-Loaiza, Alberto A., et al.
Publicado: (2021) -
Short-Course Treatment With Imipramine Entrapped in Squalene Liposomes Results in Sterile Cure of Experimental Visceral Leishmaniasis Induced by Antimony Resistant Leishmania donovani With Increased Efficacy
por: Mukherjee, Sandip, et al.
Publicado: (2020) -
Neurological toxicity due to antimonial treatment for refractory visceral leishmaniasis
por: Maristany Bosch, Marta, et al.
Publicado: (2021) -
Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis
por: Vargas, Deninson Alejandro, et al.
Publicado: (2019)